This publication is intended as an educational resource for New Zealand health professionals who manage older patients with heart failure, chronic kidney disease and type 2 diabetes. The focus of this publication is on the role of the sodium-glucose cotransporter 2 (SGLT2) inhibitors in this patient population.
Please login below to download this issue (PDF)